N/A
N=30
Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational Diabetes
Gestational Diabetes Mellitus
Bottom Line
View on ClinicalTrials.gov: NCT01681147 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
May 2023
Primary outcome: Primary: Weight Loss — 0; 0; 2 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- 2 online nutrition and exercise education classes (Behavioral); Self monitoring of blood glucose levels (Behavioral)
- Age
- Adult · 21+ yrs
- Sex
- Female
- Sponsor
- Joslin Diabetes Center
- Primary completion
- Jan 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Weight Loss |
0; 0; 2 | — |
| PRIMARY Postpartum Diabetes Screening at One Year |
0; 1; 1 | — |
| PRIMARY Barriers Associated With Poorer Adherence to Diabetes Screening Guidelines and Weight Loss Goals |
2.08; 2.20; 2.52; 1.60; 1.57; 1.97 | — |
| SECONDARY Dietary Pattern Assessment of Women With Gestational Diabetes Postpartum |
2.46; 2.77; 2.4; 1.57; 1.53; 1.69 | — |
| SECONDARY Food Frequency Questionnaire |
87.5; 20.0; 50.0; 57.1; 60.0; 42.9 | — |
| SECONDARY Exercise Frequency in Women With Gestational Diabetes Post-Partum |
3.4; 1.7; 2.2; 3.0; 2.2; 2.6 | — |
Summary
The purpose of this study is to find out whether women who have had gestational diabetes mellitus (GDM) will make healthier lifestyle choices, achieve weight goals, and complete postpartum care assessments after receiving two online classes on healthy nutrition and exercise classes at 6 weeks - 3 months and at 9 months postpartum.
Eligibility Criteria
Inclusion Criteria
- Gestational Diabetes
- Age between 21 and 45 years
- Preconception BMI 19-40
- Seen for at least 2 visits in the Diabetes in Pregnancy Program during their pregnancy
- Singleton pregnancy
Exclusion Criteria
- Preexisting diabetes or diabetes diagnosed at the 6 week 75 gram 2 hour OGTT
- BMI >40
- Multiple gestation (i.e., twins, triplets, etc.)
Data sourced from ClinicalTrials.gov (NCT01681147). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.